Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study ; volume:10 ; number:1 ; day:3 ; month:5 ; year:2024 ; pages:1-9 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (3.5.2024), 1-9, 12.2024
- Urheber
-
Matarazzo, Michele
Pérez-Soriano, Alexandra
Vafai, Nasim
Shahinfard, Elham
Cheng, Kevin Ju-Chieh
McKenzie, Jessamyn
Neilson, Nicole
Miao, Qing
Schaffer, Paul
Shinotoh, Hitoshi
Kordower, Jeffrey H.
Sossi, Vesna
Stoessl, A. Jon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00708-z
- URN
-
urn:nbn:de:101:1-2407142127579.151811116537
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Matarazzo, Michele
- Pérez-Soriano, Alexandra
- Vafai, Nasim
- Shahinfard, Elham
- Cheng, Kevin Ju-Chieh
- McKenzie, Jessamyn
- Neilson, Nicole
- Miao, Qing
- Schaffer, Paul
- Shinotoh, Hitoshi
- Kordower, Jeffrey H.
- Sossi, Vesna
- Stoessl, A. Jon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Molecular pathways to Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Life style and Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Molecular pathways to Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Life style and Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
The Parkinson’s disease-related kinase Pink1 mediates mitochondrial quality control
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
Molecular pathways to Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
The heterogeneity of Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease